National Comprehensive Cancer Network

|
|
|
|
For Patients

About NCCN

Breast Cancer Panel

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Craig Allred, MD

Pfizer Inc.

Genomic Health, Inc.;
Clarient, Inc.

Clarient, Inc

None

10/29/2009

Benjamin O. Anderson, MD

None

None

None

None

10/29/2009

Harold J. Burstein, MD, PhD

None

None

None

None

10/29/2009

Robert W. Carlson, MD

AstraZeneca Pharmaceuticals LP;
Genentech, Inc.;
Pfizer Inc.

AstraZeneca Pharmaceuticals LP;
Genentech, Inc.;
Pfizer Inc.

None

None

10/29/2009

W. Bradford Carter, MD

None

None

None

None

9/8/2008

Stephen B. Edge, MD

None

None

None

None

8/4/2009

John K. Erban, MD

None

Macrogenics;
Transmolecular, Inc

None

None

7/22/2009

William B. Farrar, MD

None

None

None

None

10/29/2009

Andres Forero, MD

Biogen Idec;
Daiichi- Sankyo Co.;
Eli Lilly and Company;
Genentech, Inc.;
BioCryst;
Immunomedics;
Seattle Genetics

None

None

None

9/28/2009

Lauren Gallagher, PhD

None

None

None

None

8/28/2009

Sharon Hermes Giordano, MD, MPH

None

None

None

None

11/3/2009

Lori J. Goldstein, MD

AstraZeneca Pharmaceuticals LP;
Bristol-Myers Squibb Company;
Genomic Health, Inc.;
GlaxoSmithKline;
Merck & Co., Inc.;
sanofi-aventis U.S.;
Wyeth Pharmaceuticals

Amgen Inc.;
AstraZeneca Pharmaceuticals LP;
Bristol-Myers Squibb Company;
Eisai Inc.;
Eli Lilly and Company;
Genentech, Inc.;
Genomic Health, Inc.;
GlaxoSmithKline;
Novartis Pharmaceuticals Corporation;
Pfizer Inc.;
Pharmion Corporation;
Roche Laboratories, Inc.;
sanofi-aventis U.S.

None

None

11/4/2009

William J. Gradishar, MD

None

None

None

None

5/13/2009

Kristina M Gregory, RN, MSN, OCN

None

None

None

None

8/21/2009

Daniel F. Hayes, MD

AstraZeneca Pharmaceuticals LP;
GlaxoSmithKline;
Novartis Pharmaceuticals Corporation;
Pfizer Inc.;
Veridex, LLC;
Wyeth Pharmaceuticals

GlaxoSmithKline;
Compendia Bioscience;
Curalogic SAB/Denmark;
DNAR;
Incyte Corp.;
Pfizer Inc.;
sanofi-aventis U.S.

Oncimmune LLC

None

11/16/2009

Clifford A. Hudis, MD

Genentech, Inc.;
Onyx Pharmaceuticals, Inc.;
Roche Laboratories, Inc.

Bayer HealthCare;
Boehringer Ingelheim GmbH;
Genentech, Inc.;
sanofi-aventis U.S.

None

None

7/1/2009

Mohammad Jahanzeb, MD, FACP

Genentech, Inc.;
Oxigene;
Pfizer Inc.

Abraxis Bioscience, Inc.;
AstraZeneca Pharmaceuticals LP;
Eli Lilly and Company;
Genentech, Inc.;
GlaxoSmithKline;
Pfizer Inc.;
sanofi-aventis U.S.

None

None

10/29/2009

Britt-Marie E. Ljung, MD

National Cancer Institute

Versant ventures

None

None

7/7/2009

P. Kelly Marcom, MD

Bristol-Myers Squibb Company;
Genentech, Inc.;
National Cancer Institute;
Novartis Pharmaceuticals Corporation

AstraZeneca Pharmaceuticals LP;
Genentech, Inc.

None

None

11/19/2009

Ingrid A. Mayer, MD

None

None

None

None

7/1/2009

Joan S McClure, MS

None

None

None

None

9/28/2009

Beryl McCormick, MD

None

None

None

None

10/9/2009

Susan Moench, PhD

None

None

None

None

7/1/2009

Lori J. Pierce, MD

None

None

None

None

8/4/2009

Elizabeth C. Reed, MD

None

UnitedHealthcare

None

None

11/2/2009

Dorothy Shead, MS

None

None

None

None

9/29/2009

Mary Lou Smith, JD, MBA

None

Eli Lilly and Company

None

None

10/29/2009

George Somlo, MD

American BioSciences Inc.;
AstraZeneca Pharmaceuticals LP;
National Cancer Institute;
Abraxane

Bristol-Myers Squibb Company;
Genentech, Inc.;
Novartis Pharmaceuticals Corporation;
Abraxane;
Roche Laboratories, Inc.

None

None

11/2/2009

Neal S. Topham, MD

None

None

None

None

10/6/2009

John H. Ward, MD

None

Strategic Consultants International

None

None

7/3/2009

Eric P. Winer, MD

Genentech, Inc.

None

None

None

9/30/2009

Antonio C. Wolff, MD

Genentech, Inc.;
Roche Laboratories, Inc.

None

None

None

11/2/2009

 

NCCN Website Supporters